Investing in Latona Life Sciences, Inc.
Latona is a privately-held specialty company dedicated to the development and commercialization of pharmaceuticals in key therapeutic orphan drug markets.
Oralgam™, Latona’s lead product candidate, has shown efficacy in the treatment of Juvenile Idiopathic Arthritis in a phase II clinical trial in an extension of the IND.
Latona is in the process of evaluating licensing opportunities for additional therapeutic assets and has identified licensing opportunities.
If you are interested in investment opportunities, please contact us directly.
Latona Life Sciences, Inc.
23623 N. Scottsdale Road
Scottsdale, AZ 85255